ProShare Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

ProShare Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-70,550	Closed	-$3.8M	–	1800
2017 Q4	$3.8M	Buy	70,550 +61,077	+645%	+$3.34M	0.03%	483
2017 Q3	$541K	Sell	9,473 -263	-3%	-$15.4K	0.01%	930
2017 Q2	$586K	Sell	9,736 -1,499	-13%	-$85.4K	0.01%	901
2017 Q1	$612K	Buy	+11,235	New	+$553K	0.01%	938

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

ProShare Advisors's BIVV Position: Q1 2018 in Review

ProShare Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 70,550 shares — an estimated $3.8M sold.

ProShare Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3.8M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

ProShare Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
ProShare Advisors sold 70,550 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3.8M.
ProShare Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
ProShare Advisors's Bioverativ Inc. Common Stock position peaked at $3.8M in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.